Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 0615-8084

5 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0615-8084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Cyclobenzaprine HCl 10mg 8084 1)

Image (Cyclobenzaprine HCl 10mg 8084 1)
Chemical structure of Cyclobenzaprine Hydrochloride depicting a tricyclic ring system with an attached side chain including a dimethylamine group and hydrochloride (HCl) salt.*
FDA Label Image

Image (Cyclobenzaprine HCl 10mg 8084 2)

Image (Cyclobenzaprine HCl 10mg 8084 2)
A data table comparing the incidence percentages of adverse events including drowsiness, dry mouth, fatigue, and headache among subjects taking Cyclobenzaprine HCl Tablets at 5 mg, 10 mg, and placebo. The table shows counts of subjects in each group and lists the percentage of subjects experiencing each adverse event by treatment group.*
FDA Label Image

Image (Cyclobenzaprine HCl 10mg 8084 3)

Image (Cyclobenzaprine HCl 10mg 8084 3)
Table presenting adverse event rates during clinical studies and surveillance programs for Cyclobenzaprine Hydrochloride 10 mg tablets. It compares the percentages of drowsiness, dry mouth, and dizziness reported in clinical trials versus post-marketing surveillance.*
FDA Label Image

Cyclobenzaprine HCl Tabs Usp 10mg Bingo Card Label (Cyclobenzaprine HCl 10mg 8084 4)

Cyclobenzaprine HCl Tabs Usp 10mg Bingo Card Label (Cyclobenzaprine HCl 10mg 8084 4)
Cyclobenzaprine Hydrochloride Tabs USP 10 mg film-coated tablets packaging label shows the product name, strength, and dosage form. It includes barcodes, lot number 8084, and quantity 30. The labeler is NCS HealthCare of KY, LLC dba Vangard Labs, with manufacturing by Invagen for Cipla. Storage instructions specify 20°-25°C and institutional use only.*
FDA Label Image

Cyclobenzaprine HCl 10mg Unit Dose Label (Cyclobenzaprine HCl 10mg 8084 5)

Cyclobenzaprine HCl 10mg Unit Dose Label (Cyclobenzaprine HCl 10mg 8084 5)
Cyclobenzaprine HCl Tablets USP 10 mg film-coated tablet labels from NCS HealthCare of KY, LLC dba Vangard Labs. The sheet includes multiple identical labels showing the product name, strength 10 mg, lot number 8084, and barcodes. An additional label shows product details including quantity 30, storage instructions, Rx-only status, and repackager information: Vangard Labs, Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.